US · FDA

    United States

    Device law, data privacy, and hosting tier for United States, on one page.

    Device law

    Full section
    21st Century Cures ActCDS final guidance, 6 Jan 2026

    The most permissive regime for clinician tools, and it just got more so, but that does not help a patient-facing use case. The January 2026 CDS final guidance, which supersedes the 2022 version, broadens the non-device clinical decision support exemption: it removed the automatic time-critical equals device rule and now allows single-recommendation tools under enforcement discretion. But the guidance remains focused exclusively on tools that support a healthcare professional. It is silent on consumer-facing chatbots, symptom checkers, and patient decision support, and the earlier enforcement-discretion proposals for consumer tools were never reinstated.

    Stays out

    Education, scheduling, qualification. The same green zone as everywhere.

    Crosses in

    Patient-facing symptom triage does not fit the CDS exemption, which is built for clinician-facing software. Likely device, unsettled.

    For us

    The permissive headlines are about clinician copilots, not patient chatbots. For a patient-facing product the line is functionally the same as Australia.

    Data privacy

    Full section
    HIPAA Privacy & Security RulesState laws: CCPA/CPRA, MODPA, MHMDA

    If we act as a business associate to a clinic that is a covered entity, HIPAA applies to protected health information and a Business Associate Agreement is required, including with any subprocessor that touches that data, such as a model API. Outside HIPAA, state privacy laws fill the gap: California's CCPA and CPRA, Maryland's MODPA, and Washington's My Health My Data Act, which treats consumer health data broadly.

    For us

    The rule for any US deployment is a complete BAA chain, or de-identification before any external processing. No PHI reaches a model vendor without a BAA in place.

    Hosting tier

    Full section
    Tier 3

    Contract or consent-gated. India, United States

    Cross-border transfer is allowed in India unless a destination is restricted, and is BAA-gated in the US. A managed API is acceptable with proper consent and, in the US, a complete BAA chain. In-region processing is still preferred for trust and to satisfy clinic contracts.